Artery Disease Clinical Trials

573 recruitingLast updated: July 25, 2026

There are 573 actively recruiting artery disease clinical trials across 67 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1. Top locations include Seoul, South Korea, New York, New York, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Artery Disease Trials at a Glance

573 actively recruiting trials for artery disease are listed on ClinicalTrialsFinder across 6 cities in 67 countries. The largest study group is Not Applicable with 243 trials, with the heaviest enrollment activity in Seoul, New York, and Beijing. Lead sponsors running artery disease studies include Fundación EPIC, Seung-Jung Park, and China National Center for Cardiovascular Diseases.

Browse artery disease trials by phase

Treatments under study

About Artery Disease Clinical Trials

Looking for clinical trials for Artery Disease? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Artery Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Artery Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 573 trials

Recruiting
Not Applicable

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Coronary Artery Disease
Teleflex150 enrolled23 locationsNCT06779630
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Arterial Occlusive DiseasesPainCardiovascular Diseases+12 more
Teleflex1,859 enrolled2 locationsNCT07258290
Recruiting

Coronary Laser Atherectomy Registry From an International Taskforce

stable coronary artery diseaseAcute Coronary Syndromes
Ceric Sàrl500 enrolled1 locationNCT07348341
Recruiting
Not Applicable

Virtue® SAB in the Treatment of Coronary ISR Trial

Coronary Artery Disease
Orchestra BioMed, Inc740 enrolled15 locationsNCT07045194
Recruiting

CPB and Aortic Cross-Clamp Durations and ICU Length of Stay After CABG Retrospective Observational Cohort Study

Coronary Artery Disease
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital400 enrolled1 locationNCT07711951
Recruiting
Not Applicable

THE EFFECT OF CARDİAC REHABİLİTATİON ON FERROPTOSİS İN PATİENTS WİTH CORONARY ARTERY DİSEASE

Coronary Artery Disease (CAD)Cardiac RehabFerroptosis
TC Erciyes University90 enrolled1 locationNCT07722637
Recruiting
Not Applicable

BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

Coronary Artery Disease (CAD)
B. Braun Melsungen AG2,184 enrolled3 locationsNCT07363161
Recruiting
Phase 3

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

Coronary Artery Disease ProgressionPremature AtherosclerosisCoronary Artery Disease Risk Factors Multiple+1 more
Duke University1,500 enrolled23 locationsNCT07232069
Recruiting
Not Applicable

Digital Long-term Follow-up of Patients With Coronary Artery Disease: a Randomized Controlled Trial

Coronary Artery Disease
Oslo University Hospital630 enrolled2 locationsNCT07720349
Recruiting

Insights From the FAST-TRACK CABG Trial: a Clinical Outcome Study in Patient With Previous Surgical Revascularization for Complex Three-vessel or Left Main Coronary Artery Disease Based on Coronary Computed Tomography Angiogram, and Fractional Flow Reserve Derived by Computed Tomography

Multivessel Coronary Artery Disease
Centro Cardiologico Monzino100 enrolled1 locationNCT07628270
Recruiting

Product Surveillance Registry

Cardiac Rhythm DisordersDigestive disordersMinimally Invasive Surgical Procedures+13 more
Medtronic100,000 enrolled400 locationsNCT01524276
Recruiting
Not Applicable

Imaging Coronary Microvascular Dysfunction (CMD) Study

Non obstructive coronary artery diseaseAngina
Icahn School of Medicine at Mount Sinai60 enrolled1 locationNCT05634031
Recruiting
Not Applicable

"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI

Coronary Artery Disease (CAD)Chronic Coronary SyndromeCoronary Bifurcation Lesion+1 more
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health50 enrolled1 locationNCT07711106
Recruiting
Not Applicable

SELUTION 4 De Novo Small Vessel IDE Trial

Coronary Artery Disease
M.A. Med Alliance S.A.960 enrolled70 locationsNCT05946629
Recruiting
Not Applicable

ULTIMATE Study (Carotid Ultrasound Vs CT Coronary Calcium Scoring to Reclassify Symptomatic Patients With Chronic Coronary Syndrome)

Obstructive coronary artery diseaseChronic Coronary Syndrome
London North West Healthcare NHS Trust225 enrolled1 locationNCT07696533
Recruiting
Phase 3

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Chronic Coronary SyndromeStable Coronary Artery Disease CAD
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.1,703 enrolled18 locationsNCT07195149
Recruiting
Not Applicable

Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

Carotid Artery Diseases
Woo-Keun Seo1,556 enrolled1 locationNCT06276374
Recruiting
Phase 1

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease

stable coronary artery diseaseHealthy Volunteers
Hoffmann-La Roche196 enrolled1 locationNCT07495813
Recruiting
Not Applicable

Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment

Coronary Artery DiseaseCoronary Calcification
Annapoorna Kini120 enrolled1 locationNCT07000045
Recruiting
Not Applicable

Hybrid Group Singing

ElderlyCoronary Artery Disease
Medical College of Wisconsin32 enrolled1 locationNCT07355192